These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6387721)
21. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369 [TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. Mehta P; Gross S; Ostrowski N Am J Pediatr Hematol Oncol; 1985; 7(1):88-91. PubMed ID: 2994511 [No Abstract] [Full Text] [Related]
23. Maternal prostacyclin, thromboxane, and placental blood flow. Ylikorkala O; Jouppila P; Kirkinen P; Viinikka L Am J Obstet Gynecol; 1983 Mar; 145(6):730-2. PubMed ID: 6338724 [TBL] [Abstract][Full Text] [Related]
28. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin. Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766 [TBL] [Abstract][Full Text] [Related]
29. Effect of amnioscopy on concentrations of prostaglandin F2 alpha, prostacyclin and thromboxane in maternal plasma. Ylikorkala O; Viinikka L Gynecol Obstet Invest; 1982; 13(3):150-4. PubMed ID: 6954125 [TBL] [Abstract][Full Text] [Related]
30. Maternal thromboxane, prostacyclin, and umbilical blood flow in humans. Ylikorkala O; Jouppila P; Kirkinen P; Viinikka L Obstet Gynecol; 1984 May; 63(5):677-80. PubMed ID: 6546976 [TBL] [Abstract][Full Text] [Related]
31. In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans. Nowak J; FitzGerald GA Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():208-11. PubMed ID: 2959050 [No Abstract] [Full Text] [Related]
32. [The effect of x-ray contrast media on the amount of thromboxane and prostacyclin in the blood of man and rats in vivo and in vitro]. Napolov IuK; Shimanovskiĭ NL; Bolotova EN; Borsukova NM; Sergeev PV Eksp Klin Farmakol; 1993; 56(5):41-3. PubMed ID: 8312809 [TBL] [Abstract][Full Text] [Related]
33. Raised plasma levels of thromboxane B2 in systemic mastocytosis. Ouwendijk RJ; Zijlstra FJ; Wilson JH; Bonta IL; Vincent JE; Stolz E Eur J Clin Invest; 1983 Jun; 13(3):227-9. PubMed ID: 6409646 [TBL] [Abstract][Full Text] [Related]
34. Correlation between umbilical artery resistance index, 6 ketoprostaglandin F1 alpha and thromboxane B2 in the fetoplacental compartment in patients with pregnancy induced hypertension. Mahmoud TZ; Bjornsson S; Kelly RW; Calder AA Prostaglandins; 1993 Jun; 45(6):509-15. PubMed ID: 8337411 [TBL] [Abstract][Full Text] [Related]
35. Streptococcus pneumoniae-induced alterations in levels of circulating thromboxane and prostacyclin: dissociation from granulocytopenia, thrombocytopenia, and pulmonary leukostasis. Goldblum SE; Wu KM; Tai HH J Infect Dis; 1986 Jan; 153(1):71-7. PubMed ID: 3510262 [TBL] [Abstract][Full Text] [Related]
36. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans. Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531 [No Abstract] [Full Text] [Related]
37. Circulating prostacyclin and thromboxane in patients with Graves' disease. Kazama Y; Kanemaru Y; Noguchi T; Onaya T Prostaglandins Leukot Med; 1987 Jan; 26(1):75-84. PubMed ID: 3543972 [TBL] [Abstract][Full Text] [Related]
38. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock. Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018 [TBL] [Abstract][Full Text] [Related]